DK0813870T3 - Anvendelse af darifenacin til at forstærke kognitive funktioner - Google Patents

Anvendelse af darifenacin til at forstærke kognitive funktioner

Info

Publication number
DK0813870T3
DK0813870T3 DK97303879T DK97303879T DK0813870T3 DK 0813870 T3 DK0813870 T3 DK 0813870T3 DK 97303879 T DK97303879 T DK 97303879T DK 97303879 T DK97303879 T DK 97303879T DK 0813870 T3 DK0813870 T3 DK 0813870T3
Authority
DK
Denmark
Prior art keywords
darifenacin
cognitive functions
enhance cognitive
treatment
pharmaceutically acceptable
Prior art date
Application number
DK97303879T
Other languages
Danish (da)
English (en)
Inventor
Michael John Allen
Brian Frank Johnson
Brian Robert Leaker
Robert Michael Wallis
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0813870T3 publication Critical patent/DK0813870T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/01Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01007Acetylcholinesterase (3.1.1.7)

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Eletrric Generators (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Soil Working Implements (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Chemical Treatment Of Metals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK97303879T 1996-06-18 1997-06-05 Anvendelse af darifenacin til at forstærke kognitive funktioner DK0813870T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9612710.5A GB9612710D0 (en) 1996-06-18 1996-06-18 Method of treatment

Publications (1)

Publication Number Publication Date
DK0813870T3 true DK0813870T3 (da) 2003-08-18

Family

ID=10795468

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97303879T DK0813870T3 (da) 1996-06-18 1997-06-05 Anvendelse af darifenacin til at forstærke kognitive funktioner

Country Status (15)

Country Link
US (1) US5837724A (pt)
EP (1) EP0813870B1 (pt)
JP (1) JP3453493B2 (pt)
KR (1) KR980000445A (pt)
AT (1) ATE243514T1 (pt)
AU (1) AU2495697A (pt)
CA (1) CA2208111C (pt)
DE (1) DE69722999T2 (pt)
DK (1) DK0813870T3 (pt)
ES (1) ES2197972T3 (pt)
GB (1) GB9612710D0 (pt)
HU (1) HUP9701060A3 (pt)
IL (1) IL121036A0 (pt)
PT (1) PT813870E (pt)
ZA (1) ZA975311B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19707655A1 (de) * 1997-02-26 1998-08-27 Hoechst Ag Kombinationspräparat zur Anwendung bei Demenz
US20040209849A1 (en) * 1998-11-27 2004-10-21 Sanochemia Pharmazeutika Aktiengesellschaft Use of effectors of the central cholinergic nervous system for treatment of delirium
GB0207104D0 (en) * 2002-03-26 2002-05-08 Pfizer Ltd Stable hydrate of a muscarinic receptor antagonist
WO2004089892A2 (en) * 2003-04-01 2004-10-21 Theravance, Inc. Diarylmethyl and related compounds having beta2 andrenergic receptor agonist and muscarinic receptor antagonist activity
ES2634421T3 (es) 2008-03-27 2017-09-27 Chase Pharmaceuticals Corporation Uso y composición para tratar la demencia
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
HUE044653T2 (hu) * 2009-07-22 2019-11-28 PureTech Health LLC Készítmények olyan rendellenességek kezelésére, amelyek muszkarin-receptor aktiválással enyhíthetõk
KR102627787B1 (ko) * 2017-06-01 2024-01-23 에자이 알앤드디 매니지먼트 가부시키가이샤 피라졸로퀴놀린 유도체와 도네페질을 병용한 치매 치료제
SG11202102349PA (en) 2018-09-28 2021-04-29 Karuna Therapeutics Inc Compositions and methods for treating disorders ameliorated by muscarnic receptor activation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5233053A (en) * 1989-03-17 1993-08-03 Pfizer Inc. Pyrrolidine derivatives
GB9400600D0 (en) * 1994-01-14 1994-03-09 Pfizer Ltd Treatment of motion seckness

Also Published As

Publication number Publication date
HUP9701060A2 (hu) 1998-12-28
PT813870E (pt) 2003-10-31
ES2197972T3 (es) 2004-01-16
JPH1059848A (ja) 1998-03-03
HU9701060D0 (en) 1997-08-28
HUP9701060A3 (en) 1999-03-29
EP0813870B1 (en) 2003-06-25
DE69722999T2 (de) 2003-12-18
US5837724A (en) 1998-11-17
CA2208111C (en) 2002-10-15
DE69722999D1 (de) 2003-07-31
ATE243514T1 (de) 2003-07-15
CA2208111A1 (en) 1997-12-18
IL121036A0 (en) 1997-11-20
EP0813870A1 (en) 1997-12-29
AU2495697A (en) 1998-01-08
KR980000445A (ko) 1998-03-30
ZA975311B (en) 1998-12-17
GB9612710D0 (en) 1996-08-21
JP3453493B2 (ja) 2003-10-06

Similar Documents

Publication Publication Date Title
PT936908E (pt) Derivados anticonvulsivos uteis no tratamento de esclerose lateral amiotrofica (ela)
DE69726189D1 (de) Mikrokeratom
LV12579B (lv) Veja energetiska iekarta un energijas parveidosanas panemiens
PT901487E (pt) 4(3h)-quinazolinonas 2,3,6-trissubstituidas
DK0799819T3 (da) 1-Dimethylaminomethyl-2-phenylcycloalk-2-enforbindelser med analgesisk virkning
DE69733470D1 (de) Laserbearbeitung
DK0813870T3 (da) Anvendelse af darifenacin til at forstærke kognitive funktioner
DE29609021U1 (de) Schutzbrille
FI980860A0 (fi) Laserarrangemang med reglerbar vaoglaengd
TR199501714A1 (tr) Bosluklar iceren sogurucu cisim.
DE59702263D1 (de) Reinigung von p.p-Bisphenolat-Lösungen
DK1052991T3 (da) Topisk anvendelse af loperamid til behandling af mikrobielle infektioner
DE29613426U1 (de) Schutzbrille
IT233164Y1 (it) Brandina o cuccia pieghegole e/o smontabile.
DK0661058T3 (da) Anvendelse af bradykininantagonister til behandling af virussygdomme
FR2709944B1 (fr) Agrafe chirurgicale.
NL1000434C2 (nl) Acetyleencopolymeren en membranen daarvan.
DE29816908U1 (de) Aufkleb- und ablösbare Wasserwaage
ES1028150Y (es) Pieza de lastre utilizada en cinturones de actividades subacuaticas.
ES1033996Y (es) Maquina trituradora-seleccionadora de gravas y similares.
KR970050684U (ko) 졸음방지용 모자
DE29606283U1 (de) Schlüssel, Schlüsselkopf und Schlüsselrohling
FI962173A0 (fi) Med bladskydd foersedd saogstaellning
KR970057937U (ko) 졸음 방지기
KR970057938U (ko) 졸음 방지기